claim: researchers working on decoy structures to fool covid-19
evidence_1: elizabeth says: april 11, 2020 at 9:50 am acting as a decoy, \"human recombinant soluble angiotensin-converting enzyme 2 (hrsace2) is soon to be tested in clinical trials by the european biotech company apeiron biologics, is useful as an antiviral therapy for covid-19, says dr. art slutsky, a scientist at the keenan research centre for biomedical science of st. michaels hospital and professor at the university of toronto who is a collaborator on the study.", "6 summary: researchers are working to create a decoy molecule that can trick coronavirus by attracting it before it can attach to lung cells, thus lowering the infection risk of covid-19.", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "source: victoria university of wellington a decoy molecule that fools coronavirus by attracting it before it can attach to lung cells may provide a way forward in the fight against covid-19.")